Ads
related to: prostate cancer hormone therapy prognosis options treatment- Prostate Cancer Treatment
Download our Prostate Cancer Guide
Find Prostate Cancer Treatments
- Prostate Cancer
Discover Prostate Cancer Treatments
Download our Prostate Cancer Guide
- Need a Second Opinion?
Put Our Expertise to Work for You.
Get a Virtual Second Opinion Today.
- Schedule an Appointment
Schedule an Appointment Today
Call our Cancer Answer Line
- Prostate Cancer Treatment
Search results
Results from the WOW.Com Content Network
Five-year survival rates range from 30–99%, depending on stage. [1] Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder. Abnormal growth of prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA ...
Radiation therapy is commonly used in prostate cancer treatment. It may be used instead of surgery or after surgery in early-stage prostate cancer (adjuvant radiotherapy). Radiation treatments also can be combined with hormonal therapy for intermediate risk disease, when surgery or radiation therapy alone is less likely to cure the cancer.
Androgen deprivation therapy. Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones ...
“Adjuvant” cancer treatment refers to any therapy you receive after your initial, primary cancer treatment. "Neoadjuvant therapy” refers to supplemental cancer treatment you receive before ...
STAMPEDE (clinical trial) Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.
A 2019 study looked into the diagnosis and treatment costs with Medicare for prostate cancer that has not spread to other parts of the body. Researchers estimated that for males 70 years old and ...
Degarelix. Degarelix, sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer. [3][5] Testosterone is a male hormone that promotes growth of many prostate tumours and therefore reducing circulating testosterone to very low (castration) levels is often the treatment goal in the management ...
Myth: Testosterone Increases Your Risk of Prostate Cancer "Concerns that testosterone stimulates or promotes cancer growth in men with underlying disease has been pretty controversial," says James ...
Ads
related to: prostate cancer hormone therapy prognosis options treatment